Decrease of Neuropsychiatric Side Effects After Switching From Atripla to Eviplera
Condition(s):HIVLast Updated:April 27, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):HIVLast Updated:April 27, 2017Terminated
Condition(s):Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been PerformedLast Updated:February 21, 2023Completed
Condition(s):HIV-1-infectionLast Updated:March 27, 2024Recruiting
Condition(s):Infection, Human Immunodeficiency VirusLast Updated:January 13, 2017Completed
Condition(s):HIV InfectionsLast Updated:December 15, 2023Recruiting
Condition(s):Human Immunodeficiency Virus; Hepatitis C, ChronicLast Updated:November 14, 2022Completed
Condition(s):HIV-1 InfectionLast Updated:September 25, 2023Completed
Condition(s):HIV/AIDSLast Updated:June 15, 2022Recruiting
Condition(s):HIV-1-infectionLast Updated:February 5, 2020Unknown status
Condition(s):HIV-1-infectionLast Updated:July 17, 2019Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.